Hofseth Biocare ASA
OSE:HBC

Watchlist Manager
Hofseth Biocare ASA Logo
Hofseth Biocare ASA
OSE:HBC
Watchlist
Price: 2.08 NOK 3.48% Market Closed
Market Cap: 821.8m NOK

Wall Street
Price Targets

HBC Price Targets Summary
Hofseth Biocare ASA

There are no price targets for HBC.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Hofseth Biocare ASA Competitors:
Price Targets
ATYR
aTyr Pharma Inc
237% Upside
CDNA
CareDx Inc
55% Upside
600201
Jinyu Bio-Technology Co Ltd
6% Upside
086900
Medy Tox Inc
26% Upside
ENTA
Enanta Pharmaceuticals Inc
134% Upside
300122
Chongqing Zhifei Biological Products Co Ltd
48% Upside
LTRN
Lantern Pharma Inc.
595% Upside
2616
CStone Pharmaceuticals
39% Downside

Revenue
Forecast

Revenue Estimate
Hofseth Biocare ASA

For the last 13 years the compound annual growth rate for Hofseth Biocare ASA's revenue is 51%. The projected CAGR for the next 9 years is -8%.

51%
Past Growth
-8%
Estimated Growth
Estimates Accuracy
-15%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Hofseth Biocare ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
99%
Average Beat

Net Income
Forecast

Net Income Estimate
Hofseth Biocare ASA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-68%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HBC's stock price target?
Not Available

HBC doesn't have any price targets made by Wall Street professionals.

What is Hofseth Biocare ASA's Revenue forecast?
Projected CAGR
-8%

For the last 13 years the compound annual growth rate for Hofseth Biocare ASA's revenue is 51%. The projected CAGR for the next 9 years is -8%.

Back to Top